Serum lipids of pemphigus foliaceus patients on long-term glucocorticoid therapy

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 36, Issue 1, 2003, Pages 1-4

  De Carvalho da Cunha, Selma Freire ^a   Modesto Dos Santos, Vitorino ^a   Monteiro, Jacqueline Pontes ^a   Ferreira, Tácio Pierre Sousa ^a   Modesto dos Santos, Jenner Arruda ^a   Modesto dos Santos, Taciana Arruda ^a   Da Cunha, Daniel Ferreira ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Glucocorticoid therapy; Pemphigus foliaceus; Serum lipids; Triglycerides

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PREDNISONE; TRIACYLGLYCEROL; URIC ACID; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FAT INTAKE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LONG TERM CARE; MALE; PEMPHIGUS FOLIACEUS; PROTEIN INTAKE; TRIACYLGLYCEROL BLOOD LEVEL;

PEMPHIGUS;

EID: 0038440699     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822003000100001     Document Type: Article

References (15)

1. Bakkaloglu A, Kirel B, Ozen S, Saatci U, Topaloglu R, Besbas N. Plasma lipids and lipoproteins in juvenile chronic arthritis. Clinical Rheumatology 15: 341-345, 1996.
2. Barraviera SRCS, Dillon NL, Curi PR, Pereira PCM, Almeida DB. Evaluation of nutritional status in patients with endemic pemphigus foliaceus. Revista do Instituto de Medicina Tropical de São Paulo 37: 51-58, 1995.
3. Berg AL, Nilsson-Ehle P. ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease. Kidney International 50: 538-542, 1996.
4. Borba EF, Bonfa E. Long term beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy, Journal of Rheumatology 28: 780-785, 2001.
5. Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Archives of Dermatology 132: 203-212, 1996.
6. Cunha DF, Cunha SFC, Monteiro JP, Ferreira TPS, Santos JAM, Furtado RA, Marssaro RS, Muniz RA, Gomes RAS. Nutritional evaluation of pemphigus foliaceus patients on long term glucocorticoid therapy. Revista do Instituto de Medicina Tropical de São Paulo 42: 23-26, 2000.
7. Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Selective review of the literature. Oral Surgery, Oral Medicine, Oral Pathology 77: 555-571, 1994.
8. Feingold KR, Hardardottir I, Grunfeld C. Beneficial effects of cytokine induced hyperlipidemia. Zeitschift fur Ernahrungswissenschaft 37 (supl 1): 66-74, 1998.
9. Franquini Junior J, Adad SJ, Murta AH, Morais CA, Teixeira VPA, Rodrigues Junior V. Tests of inflammatory activity in endemic pemphigus foliaceus. Revista da Sociedade Brasileira de Medicina Tropical 27: 25-29, 1994.
10. Friedman H, Campbell I, Rocha-Alvarez R, Ferrari I, Coimbra CEA, Moraes JR, Flowers NM, Stastny P, Fernandez-Viña M, Olague-Alcala M, Diaz LA. Endemic pemphigus foliaceus (fogo selvagem) in native Americans from Brazil. Journal of the American Academy of Dermatology 32: 949-956, 1995.
11. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340: 448-454, 1999.
12. Harris HW, Gosnell JE, Kumwenda ZL. The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity, Journal of Endotoxin Research 6: 421-30, 2000.
13. Ilowite NT. Hyperlipidemia and the rheumatic diseases. Current Opinion in Rheumatology 8: 455-458, 1996.
14. Mizock BA, Troglia S. Nutritional support of the hospitalized patient. Disease-a-Month 43: 349-426, 1997.
15. Santos VM, Cunha SFC, Cunha DF. Vetocidade de sedimentação das hemácias: utilidade e limitaçōes. Revista da Associação Médica Brasileira 46: 232-236, 2000.